Toxicology Testing in Pregnancy: Evaluating the Role of Social Profiling

Affiliations

¹ Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, and the Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Nicola C Perlman et al. Obstet Gynecol. 2020 Sep.

. 2020 Sep;136(3):607-609.

doi: 10.1097/AOG.0000000000003986.

¹ Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, and the Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

No abstract available

References

1. Maeda A, Bateman BT, Clancy CR, Creanga AA, Leffert LR. Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology 2014;121:1158–65.
1. Schiff DM, Nielsen T, Terplan M, Hood M, Bernson D, Diop H, et al. Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstet Gynecol 2018;132:466–74.
1. Massachusetts Department of Public Health. Maternal mortality and morbidity review in Massachusetts: substance use among pregnancy-associated deaths—Massachusetts, 2005–2014. Boston, MA: Massachusetts Department of Public Health; 2018.
1. Chasnoff IJ, Landress HJ, Barrett ME. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med 1990;322:1202–6.
1. Ecker J, Abuhamad A, Hill W, Bailit J, Bateman BT, Berghella V, et al. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. Am J Obstet Gynecol 2019;221:B5–28.